Earlier this year, we submitted an application for funding through the federal Strategic Innovation Fund program. Our proposal, leading a consortium of major companies, academic institutions and independent researchers, leverages the capabilities we're bringing to market in our XPSTM BioAnalyticsTM platform.
The specific goal of the project is to develop a platform capable of assessing traumatic brain injury, neurodegenerative disease, musculoskeletal injury and a range of other, age-related conditions.
The Strategic Innovation Fund allocates repayable and non-repayable contributions to firms of all sizes across all of Canada's industrial and technology sectors. The program has a budget of $1.26 billion over five years. It consolidates and simplifies the Strategic Aerospace and Defence Initiative, Technology Demonstration Program, Automotive Innovation Fund and Automotive Supplier Innovation Program.
We're thrilled to be among 12 other groups vying for a share of this highly coveted, widely regarded funding opportunity.
Read more about the SIF – Stream 4.